Neurocrine Biosciences, Inc. is showing notable market movement today, up 3.4%, or roughly $260.2 million gain.

The company has made notable gains in 12 of the last 18 trading sessions, with 6 of those days occurring consecutively from Jan 15-23.

Neurocrine Biosciences holds a market capitalization of $7.3 billion and represents 1.2% of the $592.1 billion NASDAQ/NYSE biotechnology industry.

The industry overall is down today by -0.2%, which translates to a decrease of roughly $-1.2 billion. The industry losses are led by Seattle Genetics, Inc., down -12.24%. Seattle Genetics represents 2.0% of the industry, with a market capitalization of $11.8 billion.

Historically, the average daily return for the industry in week #05 has been -0.11%, while the mode daily return is -0.02%.

With a 42stocks weight of 150.4, Neurocrine Biosciences ranks #1292 against 4394 symbols tracked, and #13 of 324 within the industry. A lower rank is more favorable, while a lower weight is less favorable.